207 related articles for article (PubMed ID: 31183364)
1. Identification of CTRP1 as a Prognostic Biomarker and Oncogene in Human Glioblastoma.
Chen L; Su G
Biomed Res Int; 2019; 2019():2582416. PubMed ID: 31183364
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
3. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
4. NAMPT, GRN, and SERPINE1 signature as predictor of disease progression and survival in gliomas.
Vachher M; Arora K; Burman A; Kumar B
J Cell Biochem; 2020 Apr; 121(4):3010-3023. PubMed ID: 31710121
[TBL] [Abstract][Full Text] [Related]
5. NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma.
Guo Q; Han N; Shi L; Yang L; Zhang X; Zhou Y; Yu S; Zhang M
Oncol Rep; 2019 Sep; 42(3):963-972. PubMed ID: 31322259
[TBL] [Abstract][Full Text] [Related]
6. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma.
Luo D; Xu X; Li J; Chen C; Chen W; Wang F; Xie Y; Li F
Int J Oncol; 2018 Nov; 53(5):2067-2080. PubMed ID: 30106127
[TBL] [Abstract][Full Text] [Related]
7. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
8. The mitochondria-related gene risk mode revealed p66Shc as a prognostic mitochondria-related gene of glioblastoma.
Peng G; Feng Y; Wang X; Huang W; Li Y
Sci Rep; 2024 May; 14(1):11418. PubMed ID: 38763954
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CLEC18B Associates With the Proliferation, Migration, and Prognosis of Glioblastoma.
Guo RM; Zhao CB; Li P; Zhang L; Zang SH; Yang B
ASN Neuro; 2018; 10():1759091418781949. PubMed ID: 29914265
[TBL] [Abstract][Full Text] [Related]
10. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
[No Abstract] [Full Text] [Related]
11. Human sperm-associated antigen 4 as a potential biomarker of glioblastoma progression and prognosis.
Zhao J; Liu B; Yang JA; Tang D; Wang X; Chen Q
Neuroreport; 2019 Apr; 30(6):446-451. PubMed ID: 30817682
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
Han J; Puri RK
J Neurooncol; 2018 Feb; 136(3):463-474. PubMed ID: 29168083
[TBL] [Abstract][Full Text] [Related]
13. circFLNA promotes glioblastoma proliferation and invasion by negatively regulating miR‑199‑3p expression.
Sun Y; Ma G; Xiang H; Wang X; Wang H; Zhang Y; Qie F; Li C
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34498720
[TBL] [Abstract][Full Text] [Related]
14. Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.
Liu J; Jiang J; Hui X; Wang W; Fang D; Ding L
Cell Physiol Biochem; 2018; 48(5):2074-2083. PubMed ID: 30099442
[TBL] [Abstract][Full Text] [Related]
15. miR‑378a‑3p inhibits cellular proliferation and migration in glioblastoma multiforme by targeting tetraspanin 17.
Guo XB; Zhang XC; Chen P; Ma LM; Shen ZQ
Oncol Rep; 2019 Nov; 42(5):1957-1971. PubMed ID: 31432186
[TBL] [Abstract][Full Text] [Related]
16. PD-L1 expression and prognostic impact in glioblastoma.
Nduom EK; Wei J; Yaghi NK; Huang N; Kong LY; Gabrusiewicz K; Ling X; Zhou S; Ivan C; Chen JQ; Burks JK; Fuller GN; Calin GA; Conrad CA; Creasy C; Ritthipichai K; Radvanyi L; Heimberger AB
Neuro Oncol; 2016 Feb; 18(2):195-205. PubMed ID: 26323609
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of miR-181a suppresses the formation of glioblastoma stem cells by targeting the Notch2 oncogene and correlates with good prognosis in patients with glioblastoma multiforme.
Huang SX; Zhao ZY; Weng GH; He XY; Wu CJ; Fu CY; Sui ZY; Ma YS; Liu T
Biochem Biophys Res Commun; 2017 May; 486(4):1129-1136. PubMed ID: 28389242
[TBL] [Abstract][Full Text] [Related]
18. Wild‑type IDH1 affects cell migration by modulating the PI3K/AKT/mTOR pathway in primary glioblastoma cells.
Shen X; Wu S; Zhang J; Li M; Xu F; Wang A; Lei Y; Zhu G
Mol Med Rep; 2020 Sep; 22(3):1949-1957. PubMed ID: 32705169
[TBL] [Abstract][Full Text] [Related]
19. TRAF6 correlated to invasion and poor prognosis of glioblastoma via elevating MMP9 expression.
Sun J; Zhao B; Du K; Liu P
Neuroreport; 2019 Jan; 30(2):127-133. PubMed ID: 30571666
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA‑3666 suppresses the growth and migration of glioblastoma cells by targeting KDM2A.
Shou T; Yang H; Lv J; Liu D; Sun X
Mol Med Rep; 2019 Feb; 19(2):1049-1055. PubMed ID: 30483744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]